Innoviva
Stock Forecast, Prediction & Price Target
Innoviva Financial Estimates
Innoviva Revenue Estimates
Innoviva EBITDA Estimates
Innoviva Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $391.86M N/A | $331.33M -15.44% | $310.46M -6.30% | Avg: $319.48M Low: $304.79M High: $334.17M avg. 2.90% | Avg: $345.27M Low: $334.65M High: $355.88M avg. 8.06% | Avg: $370.2M Low: $358.81M High: $381.58M avg. 7.22% | Avg: $450.8M Low: $436.94M High: $464.65M avg. 21.77% |
Net Income
% change YoY
| $368.83M N/A | $213.92M -42.00% | $179.72M -15.98% | Avg: $36.43M Low: $31.74M High: $41.12M avg. -79.72% | Avg: $42.02M Low: $40.34M High: $43.70M avg. 15.34% | Avg: $48.34M Low: $46.40M High: $50.27M avg. 15.02% | Avg: $66.37M Low: $63.72M High: $69.03M avg. 37.31% |
EBITDA
% change YoY
| $373.31M N/A | $215.57M -42.25% | $248.96M 15.48% | Avg: $254.65M Low: $242.94M High: $266.36M avg. 2.28% | Avg: $275.20M Low: $266.74M High: $283.66M avg. 8.06% | Avg: $295.07M Low: $286.00M High: $304.14M avg. 7.22% | Avg: $359.31M Low: $348.26M High: $370.36M avg. 21.77% |
EPS
% change YoY
| $4.49 N/A | $6.24 38.97% | $2.92 -53.20% | Avg: $1.01 Low: $0.88 High: $1.14 avg. -65.41% | Avg: $1.17 Low: $1.12 High: $1.21 avg. 15.34% | Avg: $1.34 Low: $1.29 High: $1.39 avg. 15.02% | Avg: $1.84 Low: $1.77 High: $1.91 avg. 37.31% |
Operating Expenses
% change YoY
| $16.76M N/A | $110.55M 559.49% | $132.15M 19.54% | Avg: $40.44M Low: $38.58M High: $42.30M avg. -69.39% | Avg: $43.71M Low: $42.36M High: $45.05M avg. 8.06% | Avg: $46.86M Low: $45.42M High: $48.30M avg. 7.22% | Avg: $57.07M Low: $55.31M High: $58.82M avg. 21.77% |
FAQ
What is Innoviva stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -3.01% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is 31.74M, average is 36.43M and high is 41.12M.
What is Innoviva stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.99% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $304.79M, average is $319.48M and high is $334.17M.
What is Innoviva stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 0.56% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is $0.88, average is $1.01 and high is $1.14.